Assessment of urinary osteopontin in association with podocyte for early predication of nephropathy in diabetic patients

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Al Malki, Abdulrahman L ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN M; OSTEOPONTIN; BIOLOGICAL MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NEPHRITIS; NEPHROTIC SYNDROME; PODOCYTE; PREDICTIVE VALUE; PROTEIN URINE LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; ALBUMINURIA; CASE CONTROL STUDY; DIABETIC NEPHROPATHIES; MIDDLE AGED; PATHOLOGY; URINE;

ADULT; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; HUMANS; MIDDLE AGED; OSTEOPONTIN; PODOCYTES; ROC CURVE;

EID: 84901745685     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/493736     Document Type: Article

References (25)

1. Hellemons M. E., Kerschbaum J., Bakker S. J. L., Neuwirt H., Mayer B., Mayer G., de Zeeuw D., Lambers Heerspink H. J., Rudnicki M., Validity of biomarkers predicting onset or progression of nephropathy in patients with type 2 diabetes: a systematic review. Diabetic Medicine 2012 29 5 567 577 2-s2.0-84859836382 10.1111/j.1464-5491.2011.03437.x
2. Mackinnon B., Shakerdi L., Deighan C. J., Fox J. G., O'Reilly D. S. J., Boulton-Jones M., Urinary transferrin, high molecular weight proteinuria and the progression of renal disease. Clinical Nephrology 2003 59 4 252 258 2-s2.0-0242684562 10.5414/CNP59252 (Pubitemid 36503544)
3. Narita T., Hosoba M., Kakei M., Ito S., Increased urinary excretions of immunoglobulin G, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes. Diabetes Care 2006 29 1 142 144 2-s2.0-33644874405 10.2337/diacare.29.01.06.dc05-1063 (Pubitemid 44033448)
4. Bangstad H.-J., Kofoed-Enevoldsen A., Dahl-Jorgensen K., Hanssen K. F., Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1992 35 12 1165 1169 2-s2.0-0026437647 10.1007/BF00401371
5. Gohda T., Walker W. H., Wolkow P., Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes. American Journal of Physiology-Renal Physiology 2012 303 F157 F162 10.1152/ajprenal. 00443.2011
6. Bakoush O., Tencer J., Tapia J., Rippe B., Torffvit O., Higher urinary IgM excretion in type 2 diabetic nephropathy compared to type 1 diabetic nephropathy. Kidney International 2002 61 1 203 208 2-s2.0-0036145377 10.1046/j.1523-1755.2002.00108.x (Pubitemid 34075148)
7. Mogensen C. E., Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney International 1987 31 2 673 689 2-s2.0-0023134379 10.1038/ki.1987.50 (Pubitemid 17012586)
8. Pätäri A., Forsblom C., Havana M., Taipale H., Groop P., Holthöfer H., Nephrinuria in diabetic nephropathy of type 1 diabetes. Diabetes 2003 52 12 2969 2974 2-s2.0-18344410673 10.2337/diabetes.52.12.2969 (Pubitemid 37466867)
9. Cheung G., Sahai A., Billia M., Dasgupta P., Khan M. S., Recent advances in the diagnosis and treatment of bladder cancer. BMC Medicine 2013 11 article 13
10. Thomas M. C., Burns W. C., Cooper M. E., Tubular changes in early diabetic nephropathy. Advances in Chronic Kidney Disease 2005 12 2 177 186 2-s2.0-16844378828 10.1053/j.ackd.2005.01.008 (Pubitemid 40489000)
11. Giachelli C. M., Vascular calcification: in vitro evidence for the role of inorganic phosphate. Journal of the American Society of Nephrology 2003 14 S300 S304 2-s2.0-0043037220 10.1097/01.ASN.0000081663.52165.66 (Pubitemid 37052394)
12. Fitzpatrick L. A., Severson A., Edwards W. D., Ingram R. T., Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. The Journal of Clinical Investigation 1994 94 4 1597 1604 2-s2.0-0028136961 10.1172/JCI117501
13. Zhou C., Wu J., Torres L., Hicks J. M., Bartkowiak T., Parker K., Lou Y., Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. American Journal of Nephrology 2010 32 4 324 331 2-s2.0-77955608255 10.1159/000319490
14. Yan X., Sano M., Lu L., Wang W., Zhang Q., Zhang R., Wang L., Chen Q., Fukuda K., Shen W., Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovascular Diabetology 2010 9 article 70 2-s2.0-77958566739 10.1186/1475-2840-9-70
15. Rouse R. L., Zhang J., Stewart S. R., Rosenzweig B. A., Espandiari P., Sadrieh N. K., Comparative profile of commercially available urinary biomarkers in preclinical drug-induced kidney injury and recovery in rats. Kidney International 2011 79 11 1186 1197 2-s2.0-79956039678 10.1038/ki.2010.463
16. Kestilä M., Lenkkeri U., Männikkö M., Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Molecular Cell 1998 1 575 582 10.1016/S1097-2765(00)80057-X (Pubitemid 128374693)
17. Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestila M., Jalanko H., Holmberg C., Tryggvason K., Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7962 7967 2-s2.0-0033529312 10.1073/pnas.96.14.7962 (Pubitemid 29328390)
18. Beltcheva O., Martin P., Lenkkeri U., Tryggvason K., Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Human Mutation 2001 17 5 368 373 2-s2.0-0035038042 10.1002/humu.1111 (Pubitemid 32381670)
19. Kotajima N., Kimura T., Kanda T., Obata K., Kuwabara A., Fukumura Y., Kobayashi I., Type IV collagen as an early marker for diabetic nephropathy in non-insulin-dependent diabetes mellitus. Journal of Diabetes and its Complications 2000 14 1 13 17 2-s2.0-0034594428 10.1016/S1056-8727(00)00064-7 (Pubitemid 30484033)
20. Titan S. M., Vieira J. M., Dominquez W. V., Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. Journal of Diabetes and its Complications 2012 26 546 553
21. Narita T., Sasaki H., Hosoba M., Miura T., Yoshioka N., Morii T., Shimotomai T., Koshimura J., Fujita H., Kakei M., Ito S., Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 2004 27 5 1176 1181 2-s2.0-2342460511 10.2337/diacare.27.5.1176 (Pubitemid 38579786)
22. Qin L., Zeng X., Huang G., Changes in serum and urine ceruloplasmin concentrations in type 2 diabetes. Zhong Nan Da Xue Xue Bao 2004 29 2 208 211 2-s2.0-39049181296
23. Tam F. W. K., Riser B. L., Meeran K., Rambow J., Pusey C. D., Frankel A. H., Urinary monocyte chemoattractant protein-1 (MCP-1) and connective tissue growth factor (CCN2) as prognostic markers for progression of diabetic nephropathy. Cytokine 2009 47 1 37 42 2-s2.0-67549118453 10.1016/j.cyto.2009.04. 001
24. Iijima T., Suzuki S., Sekizuka K., Follow-up study on urinary type IV collagen in patients with early stage diabetic nephropathy. Journal of Clinical Laboratory Analysis 1998 12 378 382 (Pubitemid 28531719)
25. Broedbaek K., Weimann A., Stovgaard E. S., Poulsen H. E., Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes. Free Radical Biology and Medicine 2011 51 8 1473 1479 2-s2.0-80052775577 10.1016/j.freeradbiomed.2011.07.007